Product Description: AG-636 is a potent, reversible, selective and orally active dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 of 17 nM. AG-636 has strong anticancer effects[1].
Applications: Cancer-programmed cell death
Formula: C21H17N3O2
References: [1]Gabrielle McDonald, et al. Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase. Mol Cancer Ther. 2020 Dec;19(12):2502-2515.
CAS Number: 1623416-31-8
Molecular Weight: 343.38
Compound Purity: 98.25
Research Area: Cancer
Solubility: DMSO : 31.25 mg/mL (ultrasonic)
Target: Dihydroorotate Dehydrogenase;DNA/RNA Synthesis